What Is A/G Ratio (Albumin/Globulin Ratio)? Normal vs Optimal Range Explained

Laboratories typically flag A/G ratios only when they drop below 1.0, the point where globulins overtake albumin. But meaningful imbalance starts well before that cutoff. A ratio between 1.0 and 1.2 already reflects an immune system producing more inflammatory or immunoglobulin proteins than expected relative to the liver's albumin output. Albumin alone accounts for roughly 55–65 percent of total serum protein in a healthy adult, so any sustained decline in its proportion signals a fundamental shift in hepatic synthetic capacity or inflammatory burden. The CTD maps over 5,300 compounds that interact with albumin gene expression alone, underscoring how sensitive this protein is to environmental, nutritional, and pharmacological factors. When the ratio dips below 1.2, the most common drivers are chronic low-grade inflammation elevating globulins, liver dysfunction reducing albumin production, or both occurring simultaneously—a dual-hit pattern especially common in metabolic syndrome, non-alcoholic steatohepatitis, and autoimmune disease.

PubMed indexes over 4,200 publications examining the albumin-to-globulin ratio as an independent prognostic marker across cancers, liver diseases, and inflammatory conditions. In colorectal cancer, a preoperative A/G ratio below 1.2 independently predicts worse five-year survival rates, and Clinica Chimica Acta (PMID 29170102) confirmed its prognostic value across multiple solid tumor types including lung, gastric, and breast cancer. In chronic liver disease, the ratio declines months before albumin alone drops below the flagged threshold because globulins—particularly the gamma fraction containing IgG, IgA, and IgM—rise first as the immune system responds to hepatocyte damage and increased intestinal permeability. This makes the A/G ratio an earlier warning signal than either component measured alone—the shift in balance between the two protein pools reveals dysfunction that individual values can mask when interpreted in isolation.

On the high end, an A/G ratio above 2.0 usually reflects either robust liver function with minimal immune activation—a healthy pattern in younger adults—or significant dehydration concentrating albumin levels and producing an artificially elevated reading. However, ratios persistently above 2.5 combined with total globulins below 2.0 g/dL warrant investigation for immunodeficiency conditions such as common variable immunodeficiency (CVID) or X-linked agammaglobulinemia, where the immune system underproduces protective antibodies and leaves patients vulnerable to recurrent sinopulmonary infections. The ideal 1.2–2.0 window represents a liver making plenty of transport protein while the immune system stays appropriately active without overproducing inflammatory globulins—a balance that correlates with lower cardiovascular risk, better surgical outcomes, and improved overall five-year mortality in hospitalized populations. The American Journal of Surgery (PMID 23866764) demonstrated that pretreatment A/G ratio independently predicted long-term survival outcomes across multiple disease states.